adjustable gastric banding

(ă-jŭs′tă-bl)

A bariatric surgical treatment for obesity in which a Silastic belt encircles the proximal portion of the stomach, restricting the flow of food. The rest of the gastrointestinal tract is left unmodified. The belt initially permits the proximal stomach to hold just an ounce of food. The restriction gives patients a feeling of premature fullness after a small meal, which keeps them from overeating. It can be loosened after significant weight loss has occurred to permit slightly increased food intake. Weight loss with gastric banding, which results purely from limitations on food intake, tends to be less than what can be achieved with surgery, e.g., Roux-en-Y gastric bypass. Relatively common complications of banding include nausea and vomiting, erosion of the band into the stomach, and wound infections. Some patients learn to eat slowly but continuously and fail to lose weight..

References in periodicals archive ?

Objective: To find out effectiveness of revisional laparoscopic sleeve gastrectomy (RLSG) in the patients who had laparoscopic adjustable gastric banding (LAGB) and failed to reduce or regained the weight and effectiveness of sweet abstaining and exercise on postoperative weight loss.

Revisional laparoscopic sleeve gastrectomy in failed gastric banding and effects of exercise and frequent sweet-eating on its outcome

2] who underwent laparoscopic adjustable gastric banding performed by a single surgeon and were followed for up to 11 years (mean of 10 years), 423 were aged 45 years or younger, and 405 were over age 45 years at the time of surgery.

Earlier bariatric surgery may improve CV outcomes

Of 828 patients with body mass index of at least 35 kg/m2 who underwent laparoscopic adjustable gastric banding performed by a single surgeon and were followed for up to 11 years (mean of 10 years), 423 were aged 45 years or younger, and 405 were over age 45 years at the time of surgery.

Earlier bariatric surgery may improve CV outcomes

The study reviewed the fertility outcomes after intragastric balloon placement, adjustable gastric banding, sleeve gastrectomy and gastric bypass in childbearing women with a diagnosis of infertility.

Pregnancy hopes weigh heavy on obese women

Weight loss and improvement in comorbidities are less than Roux-en-Y but definitely better then adjustable gastric banding.

Instant remedy or total salvation? Merits and demerits of bariatric surgery

Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review.

Rapidly growing mycobacteria associated with laparoscopic gastric banding, Australia, 2005-2011

Contemporary bariatric surgeries include Roux-en-Y gastric bypass, laparoscopic adjustable gastric banding, biliopancreatic diversion with duodenal switch, sleeve gastrectomy, and mini--gastric bypass.

What matters: bariatric surgery and alcohol use disorder

The most commonly used bariatric surgery techniques, according to the British Medical Journal, are Roux-en-Y gastric bypass, sleeve gastrectomy, and laparoscopic adjustable gastric banding.

New evidence: bariatric surgery also reverses the effects of aging: Telomeres, genetic biomarkers of aging, are found to be longer after the surgery

Apollo Endosurgery Inc, a developer of medical devices for endoscopic surgical procedures, has acquired the obesity intervention division of Allergan Inc, which manufactures and sells weight loss solutions comprised of the LAP-BAND[R] adjustable gastric banding system and the ORBERA(TM) intra-gastric balloon system.

Apollo Endosurgery acquires Allergan's obesity intervention division

5 ( ANI ): Researchers have found that obese patients who underwent gastric bypass or laparoscopic adjustable gastric banding surgical procedures experienced substantial weight loss three years after surgery, with most of the change occurring in the first year itself.

Patients undergoing bariatric surgery see biggest benefits within first three years

In 2001 the LAP-BAND(r) adjustable gastric banding system (LAGB) was approved by the FDA as weight loss procedure for patients with a body mass index (BMI) of 40 kg/m2 or higher and for patients with a BMI of at least 35 with an obesity-related condition, such as diabetes or hypertension.

Weight loss surgery is safe & effective for an expanded group of patients

1,2,3,4,5,6) Fewer data exist on adverse neurologic effects following adjustable gastric banding and there are no well established therapeutic interventions for these complications when they occur.

Neuropathy following laparoscopic adjustable gastric banding: treatment with plasmapheresis